Flat Capital AB (publ) (STO:FLAT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
20.10
+0.16 (0.80%)
Jul 30, 2025, 5:29 PM CET

CTI BioPharma Revenue

Flat Capital AB had revenue of -1.30M SEK in the quarter ending March 31, 2025, a decrease of -87.56%. This brings the company's revenue in the last twelve months to 117.33M, down -285.36% year-over-year. In the year 2024, Flat Capital AB had annual revenue of 108.19M, down -238.84%.

Revenue (ttm)
117.33M
Revenue Growth
-285.36%
P/S Ratio
17.44
Revenue / Employee
58.66M
Employees
2
Market Cap
2.05B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024108.19M186.11M-238.84%
Dec 31, 2023-77.92M-11.69M17.64%
Dec 31, 2022-66.24M-146.20M-182.83%
Dec 31, 202179.97M45.85M134.40%
Dec 31, 202034.12M11.80M52.87%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition